GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Curable Inc (XKRX:086460) » Definitions » Beneish M-Score

Curable (XKRX:086460) Beneish M-Score : -4.29 (As of Jun. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Curable Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.29 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Curable's Beneish M-Score or its related term are showing as below:

XKRX:086460' s Beneish M-Score Range Over the Past 10 Years
Min: -4.29   Med: -4.29   Max: -4.29
Current: -4.29

During the past 3 years, the highest Beneish M-Score of Curable was -4.29. The lowest was -4.29. And the median was -4.29.


Curable Beneish M-Score Historical Data

The historical data trend for Curable's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curable Beneish M-Score Chart

Curable Annual Data
Trend Dec21 Dec22 Dec23
Beneish M-Score
- - -4.29

Curable Semi-Annual Data
Dec21 Dec22 Dec23
Beneish M-Score - - -4.29

Competitive Comparison of Curable's Beneish M-Score

For the Diagnostics & Research subindustry, Curable's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curable's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Curable's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Curable's Beneish M-Score falls into.



Curable Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Curable for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.2254+0.528 * -0.0122+0.404 * 2.5823+0.892 * 0.5465+0.115 * 0.364
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.7357+4.679 * -0.101792-0.327 * 1.3627
=-4.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₩835.1 Mil.
Revenue was ₩211.7 Mil.
Gross Profit was ₩128.0 Mil.
Total Current Assets was ₩3,363.6 Mil.
Total Assets was ₩24,905.4 Mil.
Property, Plant and Equipment(Net PPE) was ₩8,476.6 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩1,564.6 Mil.
Selling, General, & Admin. Expense(SGA) was ₩550.7 Mil.
Total Current Liabilities was ₩9,505.9 Mil.
Long-Term Debt & Capital Lease Obligation was ₩3,465.8 Mil.
Net Income was ₩-7,809.9 Mil.
Gross Profit was ₩0.0 Mil.
Cash Flow from Operations was ₩-5,274.8 Mil.
Total Receivables was ₩6,777.4 Mil.
Revenue was ₩387.4 Mil.
Gross Profit was ₩-2.9 Mil.
Total Current Assets was ₩11,688.6 Mil.
Total Assets was ₩26,407.7 Mil.
Property, Plant and Equipment(Net PPE) was ₩9,354.5 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩562.5 Mil.
Selling, General, & Admin. Expense(SGA) was ₩580.6 Mil.
Total Current Liabilities was ₩6,710.9 Mil.
Long-Term Debt & Capital Lease Obligation was ₩3,382.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(835.051 / 211.7) / (6777.443 / 387.367)
=3.944502 / 17.496181
=0.2254

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-2.861 / 387.367) / (128.003 / 211.7)
=-0.007386 / 0.604643
=-0.0122

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3363.592 + 8476.581) / 24905.358) / (1 - (11688.573 + 9354.516) / 26407.727)
=0.524593 / 0.203147
=2.5823

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=211.7 / 387.367
=0.5465

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(562.544 / (562.544 + 9354.516)) / (1564.608 / (1564.608 + 8476.581))
=0.056725 / 0.155819
=0.364

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(550.747 / 211.7) / (580.599 / 387.367)
=2.601545 / 1.498834
=1.7357

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3465.809 + 9505.853) / 24905.358) / ((3382.238 + 6710.862) / 26407.727)
=0.520838 / 0.382203
=1.3627

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-7809.93 - 0 - -5274.757) / 24905.358
=-0.101792

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Curable has a M-score of -4.29 suggests that the company is unlikely to be a manipulator.


Curable Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Curable's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Curable (XKRX:086460) Business Description

Traded in Other Exchanges
N/A
Address
93, Dongtan-daero 23-gil, 10th Floor, Gyeonggi-do, Hwaseong-si, KOR
Curable Inc provides genome analysis service.

Curable (XKRX:086460) Headlines

No Headlines